These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9698539

  • 21. Advancements of antisense oligonucleotides in treatment of breast cancer.
    Yang SP, Song ST, Song HF.
    Acta Pharmacol Sin; 2003 Apr; 24(4):289-95. PubMed ID: 12676065
    [Abstract] [Full Text] [Related]

  • 22. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.
    Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, Campbell M, Kerner J, Goldfine ID.
    Breast Cancer Res Treat; 2005 Nov; 94(1):37-46. PubMed ID: 16142439
    [Abstract] [Full Text] [Related]

  • 23. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 24. Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model.
    Bartholomeusz C, Itamochi H, Yuan LX, Esteva FJ, Wood CG, Terakawa N, Hung MC, Ueno NT.
    Cancer Res; 2005 Sep 15; 65(18):8406-13. PubMed ID: 16166319
    [Abstract] [Full Text] [Related]

  • 25. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G.
    Hum Pathol; 2006 Sep 15; 37(9):1217-26. PubMed ID: 16938528
    [Abstract] [Full Text] [Related]

  • 26. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK, Tjan S, Parkes RK, O'Malley FP.
    Mod Pathol; 2002 Dec 15; 15(12):1318-25. PubMed ID: 12481013
    [Abstract] [Full Text] [Related]

  • 27. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
    Leers MP, Hoop JG, Nap M.
    Anticancer Res; 2003 Dec 15; 23(2A):999-1006. PubMed ID: 12820338
    [Abstract] [Full Text] [Related]

  • 28. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA.
    Cancer Res; 2002 Mar 15; 62(6):1676-81. PubMed ID: 11912139
    [Abstract] [Full Text] [Related]

  • 29. SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu.
    Wen CC, Cheng SA, Hsuen SP, Huang YL, Kuo ZK, Lee HF, Kuo CH, Du JL, Wang WB.
    Cancer Res; 2006 Jun 01; 66(11):5847-57. PubMed ID: 16740724
    [Abstract] [Full Text] [Related]

  • 30. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.
    Chang CJ, Chiu JH, Tseng LM, Chang CH, Chien TM, Wu CW, Lui WY.
    Eur J Clin Invest; 2006 Aug 01; 36(8):588-96. PubMed ID: 16893382
    [Abstract] [Full Text] [Related]

  • 31. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
    Yang DC, Jiang X, Elliott RL, Head JF.
    Anticancer Res; 2002 Aug 01; 22(3):1513-24. PubMed ID: 12168831
    [Abstract] [Full Text] [Related]

  • 32. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
    Lindemann K, Resau J, Nährig J, Kort E, Leeser B, Annecke K, Welk A, Schäfer J, Vande Woude GF, Lengyel E, Harbeck N.
    Histopathology; 2007 Jul 01; 51(1):54-62. PubMed ID: 17593080
    [Abstract] [Full Text] [Related]

  • 33. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.
    Shimada M, Imura J, Kozaki T, Fujimori T, Asakawa S, Shimizu N, Kawaguchi R.
    Oncol Rep; 2005 Apr 01; 13(4):633-41. PubMed ID: 15756435
    [Abstract] [Full Text] [Related]

  • 34. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells.
    DiPaola RS, Kuczynski WI, Onodera K, Ratajczak MZ, Hijiya N, Moore J, Gewirtz AM.
    Cancer Gene Ther; 1997 Apr 01; 4(3):176-82. PubMed ID: 9171936
    [Abstract] [Full Text] [Related]

  • 35. NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer.
    Christianson TA, Doherty JK, Lin YJ, Ramsey EE, Holmes R, Keenan EJ, Clinton GM.
    Cancer Res; 1998 Nov 15; 58(22):5123-9. PubMed ID: 9823322
    [Abstract] [Full Text] [Related]

  • 36. Expression of HER2/neu in primary and metastatic breast cancer.
    Tuziak T, Olszewski WP, Olszewski W, Pieńkowski T.
    Pol J Pathol; 2001 Nov 15; 52(1-2):21-6. PubMed ID: 11505677
    [Abstract] [Full Text] [Related]

  • 37. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
    Bertram J, Killian M, Brysch W, Schlingensiepen KH, Kneba M.
    Biochem Biophys Res Commun; 1994 Apr 15; 200(1):661-7. PubMed ID: 7909438
    [Abstract] [Full Text] [Related]

  • 38. A new cis element is involved in the HER2 gene overexpression in human breast cancer cells.
    Grooteclaes M, Vernimmen D, Plaza S, Pasleau F, Hodzic D, Winkler-Gol R.
    Cancer Res; 1999 Jun 01; 59(11):2527-31. PubMed ID: 10363966
    [Abstract] [Full Text] [Related]

  • 39. HER2 regulatory control of angiopoietin-2 in breast cancer.
    Carter WB, Ward MD.
    Surgery; 2000 Aug 01; 128(2):153-8. PubMed ID: 10922985
    [Abstract] [Full Text] [Related]

  • 40. In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice.
    Penichet ML, Challita PM, Shin SU, Sampogna SL, Rosenblatt JD, Morrison SL.
    Lab Anim Sci; 1999 Apr 01; 49(2):179-88. PubMed ID: 10331548
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.